Hologic is down approximately 20% from recent highs and continues to grow organically and via a series of 'bolt-on' ...

The stock's rise snapped a four-day losing streak.

Hologic Inc. has received a warning letter from the Food and Drug Administration regarding its BioZorb product line, even ...

Shares of Hologic Inc. HOLX slid 2.07% to $68.75 Wednesday, on what proved to be an all-around great trading session for the ...

MARLBOROUGH, Mass., January 12, 2025 -- ( BUSINESS WIRE )--Hologic, Inc. (Nasdaq: HOLX) announced today preliminary revenue ...

Hologic stopped manufacturing the device after reports of serious adverse events in patients who had the markers implanted in breast tissue.

Leerink Partners analyst Puneet Souda has maintained their bullish stance on HOLX stock, giving a Buy rating on January 13.Stay Ahead of the ...

On Wednesday, Hologic Inc (HOLX) stock saw a decline, ending the day at $68.75 which represents a decrease of $-1.45 or -2.07% from the prior close of $70.2. The stock opened at $69.97 and touched a ...

Needham analyst Michael Matson maintained a Buy rating on Hologic (HOLX – Research Report) today and set a price target of $90.00.Stay Ahead of ...

The unseeded Madison Keys captured the ninth Hologic WTA Tour title of her career, second in Adelaide (following 2022) and fourth on outdoor hard courts at the 2025 Adelaide International. Keys ...

Olga Danilovic upset Jessica Pegula in the Australian Open third round to notch her third career Top 10 win and move into the ...

Hologic Inc (HOLX) stock saw a decline, ending the day at $70.29 which represents a decrease of $-1.41 or -1.97% from the prior close of $71.7. The stock opened at $72.99 and touched a low of $69.46 ...